RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,345 | -28.7% | 22,058 | +67.2% | 0.00% | – |
| Q2 2023 | $14,508 | +80500.0% | 13,189 | -14.3% | 0.00% | -100.0% |
| Q1 2023 | $18 | +80.0% | 15,387 | +134.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 6,575 | -27.2% | 0.00% | – |
| Q3 2022 | $15,000 | +50.0% | 9,033 | -26.5% | 0.00% | – |
| Q2 2022 | $10,000 | +25.0% | 12,286 | +150.0% | 0.00% | – |
| Q1 2022 | $8,000 | 0.0% | 4,914 | +25.5% | 0.00% | – |
| Q3 2021 | $8,000 | -72.4% | 3,916 | -68.7% | 0.00% | -100.0% |
| Q2 2021 | $29,000 | +16.0% | 12,496 | +42.2% | 0.00% | – |
| Q1 2021 | $25,000 | +38.9% | 8,786 | +41.4% | 0.00% | -100.0% |
| Q4 2020 | $18,000 | -64.7% | 6,213 | -74.9% | 0.00% | 0.0% |
| Q3 2020 | $51,000 | +30.8% | 24,725 | +187.6% | 0.00% | -50.0% |
| Q2 2020 | $39,000 | +875.0% | 8,597 | +1709.9% | 0.00% | – |
| Q1 2020 | $4,000 | -85.7% | 475 | -69.1% | 0.00% | -100.0% |
| Q4 2019 | $28,000 | -15.2% | 1,538 | -47.7% | 0.00% | 0.0% |
| Q3 2019 | $33,000 | +725.0% | 2,943 | +635.8% | 0.00% | – |
| Q2 2019 | $4,000 | +33.3% | 400 | -28.6% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 560 | +43.6% | 0.00% | – |
| Q4 2018 | $3,000 | -66.7% | 390 | -68.5% | 0.00% | -100.0% |
| Q3 2018 | $9,000 | +800.0% | 1,240 | +386.3% | 0.00% | – |
| Q2 2018 | $1,000 | – | 255 | +3542.9% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 7 | -99.8% | 0.00% | -100.0% |
| Q3 2017 | $26,000 | – | 2,895 | – | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2016 | $4,000 | +300.0% | 500 | +367.3% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 107 | -40.6% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 180 | -11.8% | 0.00% | – |
| Q1 2016 | $1,000 | -87.5% | 204 | -70.1% | 0.00% | -100.0% |
| Q3 2015 | $8,000 | -50.0% | 682 | -43.0% | 0.00% | 0.0% |
| Q2 2015 | $16,000 | +700.0% | 1,197 | +51.1% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 792 | +19.8% | 0.00% | – |
| Q3 2014 | $2,000 | -80.0% | 661 | -45.1% | 0.00% | -100.0% |
| Q2 2014 | $10,000 | – | 1,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |